TNFRSF11A and breast carcinoma: A growing body of evidence points toward a critical involvement of RANKL/RANK pathway in breast cancer initiation and progression through different mechanisms, such as increased proliferation and survival of mammary epithelial cells, enhanced MaSCs expansion, and induction of EMT.